LB vs NBIX · rev $199.1M vs P/E 45, rev $2.36B
LandBridge Company LLC (LB) versus Neurocrine Biosciences Inc (NBIX) — a side-by-side from cached financials, not a winner call.
LandBridge Company LLC (LB) is a oil & gas equipment & services company listed on US.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Latest reported LB revenue for 2025-12-31 was $199.1M. Net income was $30.1M. Revenue was up 81.1% from 2024-12-31 to 2025-12-31. LB currently screens at market cap $5.54B.
Latest reported NBIX revenue for 2024-12-31 was $2.36B. Net income was $341.3M. Revenue was up 24.8% from 2023-12-31 to 2024-12-31. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
LB currently screens at market cap $5.54B. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Not investment advice. Open the LB and NBIX stock pages for the full models.
Not investment advice.